Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD
NCT03606824Unknown
- Start
- Mar 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of levothyroxine sodium in hypothyroidism and dyslipidemia. Primary endpoint: Change of LDL-C levels at 6 months. Status: unknown.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidismdyslipidemia
Beyond the preview
Go deeper on NCT03606824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03606824.